✦ LIBER ✦

Adjunctive armodafinil for negative symptoms in adults with schizophrenia: A double-blind, placebo-controlled study

✍ Scribed by John M. Kane; Ronghua Yang; James M. Youakim

Book ID: 119366036
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 262 KB
Volume: 135
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2011.11.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluvoxamine improves negative symptoms i

Fluvoxamine improves negative symptoms in treated chronic schizophrenia: An add-on double-blind, placebo-controlled study

✍ Henry Silver; Ahmed Nassar 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 382 KB

Sildenafil adjunctive therapy to risperi

Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial

✍ Shahin Akhondzadeh; Raofeh Ghayyoumi; Farzin Rezaei; Bahman Salehi; Amir-Hossein 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 154 KB

Minocycline ameliorates negative symptom

Minocycline ameliorates negative symptoms and cognitive deficits in early-phase schizophrenia: A double-blind, randomized placebo-controlled study

✍ Y. Levkovitz; S. Mendlovic; S. Issaki; Y. Braw; H. Levkovitch-Verbin; G. Gal; S. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Adjunctive estrogen treatment in women w

Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial

✍ Shahin Akhondzadeh; Ali Akbar Nejatisafa; Homayoun Amini; Mohammad Reza Mohammad 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 250 KB

The effect of adjunctive armodafinil on

The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: A randomized, double-blind, placebo-controlled trial

✍ William V. Bobo; Neil D. Woodward; Min Young Sim; Karuna Jayathilake; Herbert Y. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

A double-blind, placebo-controlled study

A double-blind, placebo-controlled study of traditional Chinese medicine sarsasapogenin added to risperidone in patients with negative symptoms dominated schizophrenia

✍ Shi-Fu Xiao; Hai-Bo Xue; Xia Li; Chao Chen; Guan-Jun Li; Cheng-Mei Yuan; Ming-Yu 📂 Article 📅 2011 🏛 Shanghai Institutes for Biological Sciences, Chine 🌐 English ⚖ 725 KB